Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    10(71%)

    Phase Distribution

    Phase 1
    14
    100%

    Phase Distribution

    14

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution14 total trials
    Phase 1Safety & dosage
    14(100.0%)

    Highest Phase Reached

    Phase 1

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 2 finished

    Non-Completion Rate

    100.0%

    2 ended early

    Currently Active

    10

    trials recruiting

    Total Trials

    14

    all time

    Status Distribution
    Active(12)
    Terminated(2)

    Detailed Status

    Recruiting10
    Not yet recruiting2
    Withdrawn2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    14
    Active
    10
    Success Rate
    N/A
    Most Advanced
    Phase 1

    Trials by Phase

    Phase 114 (100.0%)

    Trials by Status

    recruiting1071%
    not_yet_recruiting214%
    withdrawn214%

    Recent Activity

    Clinical Trials (14)

    Showing 14 of 14 trials
    NCT05003388Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS

    Recruiting
    NCT05003934Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion and Intra-Articular Injection for RA

    Recruiting
    NCT05003947Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis

    Recruiting
    NCT05003960Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

    Recruiting
    NCT05018767Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty

    Recruiting
    NCT05018819Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP

    Recruiting
    NCT05018858Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus

    Recruiting
    NCT05152290Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for SCI

    Recruiting
    NCT05158127Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Skin Ulcer

    Not Yet Recruiting
    NCT06143527Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for PCOS

    Recruiting
    NCT05003921Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for ALS

    Withdrawn
    NCT05018832Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for TBI

    Not Yet Recruiting
    NCT05147688Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Pulmonary Diseases

    Recruiting
    NCT05158439Phase 1

    Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Tourette Syndrome

    Withdrawn

    All 14 trials loaded

    Drug Details

    Intervention Type
    Biological
    Total Trials
    14